Variant report
Variant | nsv947072 |
---|---|
Chromosome Location | chr1:227709512-227712483 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:227709572-227709620 | Fibrobl | skin: | n/a | n/a |
2 | CTCF | chr1:227710101-227710223 | GM13976 | blood: | n/a | n/a |
3 | EP300 | chr1:227711426-227711443 | K562 | blood: | n/a | n/a |
4 | MYC | chr1:227709938-227709987 | GM12878 | blood: | n/a | n/a |
5 | MYC | chr1:227710049-227710123 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr1:227711275-227711645 | K562 | blood: | n/a | n/a |
7 | POLR2A | chr1:227710048-227710869 | K562 | blood: | n/a | n/a |
8 | RCOR1 | chr1:227711309-227711428 | K562 | blood: | n/a | n/a |
9 | SRF | chr1:227710076-227710201 | GM12878 | blood: | n/a | n/a |
10 | STAT3 | chr1:227711466-227711655 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | WRNIP1 | chr1:227709990-227710158 | GM12878 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:227704941..227707226-chr1:227710980..227713652,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227711 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572830150 | chr1:227709534-227709535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12132444 | chr1:227709546-227709547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs150728153 | chr1:227709587-227709588 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs575256376 | chr1:227709619-227709620 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs2492633 | chr1:227709624-227709625 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs369019958 | chr1:227709628-227709629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557566428 | chr1:227709650-227709651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78570793 | chr1:227709675-227709676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575762120 | chr1:227709688-227709689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546248648 | chr1:227709709-227709710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564242014 | chr1:227709731-227709732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565241401 | chr1:227709738-227709739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182922458 | chr1:227709811-227709812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540280014 | chr1:227709867-227709868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561629709 | chr1:227709868-227709869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114877241 | chr1:227709881-227709882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139070981 | chr1:227709902-227709903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111733060 | chr1:227709961-227709962 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs538403505 | chr1:227709992-227709993 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs1080061 | chr1:227709997-227709998 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs532985390 | chr1:227710065-227710066 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs551455548 | chr1:227710090-227710091 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs566613126 | chr1:227710094-227710095 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs78573600 | chr1:227710105-227710106 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs76732374 | chr1:227710106-227710107 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs575270698 | chr1:227710117-227710118 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs72748030 | chr1:227710126-227710127 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs72472991 | chr1:227710137-227710138 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs79311941 | chr1:227710156-227710157 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs77608259 | chr1:227710170-227710171 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs78215460 | chr1:227710176-227710177 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs533765990 | chr1:227710195-227710196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs79109717 | chr1:227710208-227710209 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs34878145 | chr1:227710218-227710219 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs74994958 | chr1:227710223-227710224 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs2256599 | chr1:227710227-227710228 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs73090923 | chr1:227710238-227710239 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs187220571 | chr1:227710254-227710255 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs139072933 | chr1:227710262-227710263 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs78155254 | chr1:227710263-227710264 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs76416714 | chr1:227710270-227710271 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs557388563 | chr1:227710311-227710312 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs575744192 | chr1:227710359-227710360 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs199643578 | chr1:227710360-227710361 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs148553515 | chr1:227710374-227710375 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs2453682 | chr1:227710381-227710382 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs557818894 | chr1:227710382-227710383 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs370406387 | chr1:227710419-227710420 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs199724642 | chr1:227710461-227710462 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs192902238 | chr1:227710465-227710466 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:227709200-227710200 | Enhancers | HSMMtube | muscle |
2 | chr1:227709600-227710200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |